🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial is studying how well romidepsin works in treating patie...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center at Suffolk
Start Date
2004-10
Trial ID
NCT00098813
Treatments Being Tested
This study evaluates the safety and tolerability of the addition of immunos...
Status
Terminated
Location
NYU Cancer Institute
Start Date
2014-03
Trial ID
NCT02061449
Treatments Being Tested
This phase I trial studies the side effects and best dose of romidepsin in ...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-08-03
Trial ID
NCT01638533
Treatments Being Tested
The goal of this clinical research study is to learn if giving romidepsin b...
Status
Completed
Location
The Ohio State University Cancer Center
Start Date
2017-12-08
Trial ID
NCT02512497
Treatments Being Tested
The purpose of this study is to evaluate the activity of FK228 in metastati...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2003-05-01
Trial ID
NCT00106613
Treatments Being Tested
The purpose of this study is to evaluate how safe and effective the combina...
Status
Completed
Location
City of Hope
Start Date
2015-06-11
Trial ID
NCT02232516
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of ext...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2004-04-01
Trial ID
NCT00106301
Treatments Being Tested
This phase II trial is studying how well romidepsin works in treating patie...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2003-05
Trial ID
NCT00062075
Treatments Being Tested
This phase I trial studies the side effects and best dose of alisertib and ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2013-07-17
Trial ID
NCT01897012
Treatments Being Tested
This phase I/II trial is studying the best dose of FR901228 when given toge...
Status
Terminated
Location
University of Maryland Greenebaum Cancer Center
Start Date
2004-01
Trial ID
NCT00079443
Treatments Being Tested